by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...
Vous n'êtes pas connecté
People taking Wegovy were not protected from infection. But in a large trial, their death rates were markedly lower, for reasons that are not clear.
by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...
Life in the United States has changed drastically in the last several decades. Technology, pharmaceutical and medical interventions, dietary shifts,...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...
By Saul Zimet During Vivek Ramaswamy’srecent eventat the Cato Institute, protestorsderailed his presentationby getting on stage and chanting...
By Saul Zimet During Vivek Ramaswamy’srecent eventat the Cato Institute, protestorsderailed his presentationby getting on stage and chanting...
By Rebecca Gordon Washington Postheadlinereads: “A big problem for young workers: 70- and 80-year-olds who won’t retire.” For the first time...
They’re never going to stop. We’re a few months away from the end of 2024, four and a half years after the start of the Covid-19 pandemic....
TUESDAY, Sept. 3, 2024 -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...